Ana Vega

11.2k total citations
95 papers, 1.9k citations indexed

About

Ana Vega is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Ana Vega has authored 95 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 37 papers in Genetics and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Ana Vega's work include BRCA gene mutations in cancer (23 papers), Genetic factors in colorectal cancer (15 papers) and DNA Repair Mechanisms (14 papers). Ana Vega is often cited by papers focused on BRCA gene mutations in cancer (23 papers), Genetic factors in colorectal cancer (15 papers) and DNA Repair Mechanisms (14 papers). Ana Vega collaborates with scholars based in Spain, United Kingdom and United States. Ana Vega's co-authors include Ángel Carracedo, Antonio Salas, Laura Fachal, Vincent Macaulay, Clara Ruíz-Ponte, L. Rodríguez‐Pazos, Orland Dı́ez, J. Toribio, Ana Blanco and Hans‐Jürgen Bandelt and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ana Vega

91 papers receiving 1.9k citations

Peers

Ana Vega
Shareef Nahas United States
Eric S. Martin United States
Abdellatif Errami Netherlands
P J Stambrook United States
Serah Choi United States
Carol A. Westbrook United States
Shareef Nahas United States
Ana Vega
Citations per year, relative to Ana Vega Ana Vega (= 1×) peers Shareef Nahas

Countries citing papers authored by Ana Vega

Since Specialization
Citations

This map shows the geographic impact of Ana Vega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Vega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Vega more than expected).

Fields of papers citing papers by Ana Vega

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Vega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Vega. The network helps show where Ana Vega may publish in the future.

Co-authorship network of co-authors of Ana Vega

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Vega. A scholar is included among the top collaborators of Ana Vega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Vega. Ana Vega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernández-Luna, José L., José L. Hernández, N. Martínez‐Amador, et al.. (2024). Osteomesopyknosis associated with a novel ALOX5 variant that impacts the RANKL pathway. Molecular Genetics & Genomic Medicine. 12(5). e2471–e2471. 1 indexed citations
2.
Garcı́a-Unzueta, Maria Teresa, Bernardo Alio Lavín, Ana Vega, et al.. (2023). Uncovering genetic causes of hypophosphatemia. Journal of Internal Medicine. 293(6). 753–762. 7 indexed citations
3.
García-Aznar, José María, et al.. (2022). New Insights into Renal Failure in a Cohort of 317 Patients with Autosomal Dominant Forms of Alport Syndrome: Report of Two Novel Heterozygous Mutations in COL4A3. Journal of Clinical Medicine. 11(16). 4883–4883. 4 indexed citations
4.
Ahmed, Mahbubl, Leila Dorling, Sarah L. Kerns, et al.. (2016). Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity. British Journal of Cancer. 114(10). 1165–1174. 18 indexed citations
5.
Fachal, Laura, Antonio Gómez‐Caamaño, Gillian C. Barnett, et al.. (2014). A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1. Nature Genetics. 46(8). 891–894. 101 indexed citations
6.
7.
Gómez‐Carballa, Alberto, Jacobo Pardo‐Seco, Laura Fachal, et al.. (2013). Indian Signatures in the Westernmost Edge of the European Romani Diaspora: New Insight from Mitogenomes. PLoS ONE. 8(10). e75397–e75397. 23 indexed citations
8.
García‐Martínez, Francisco Javier, et al.. (2013). Annular Elastolytic Giant Cell Granuloma Associated to Late-Onset X-Linked Dominant Protoporphyria. Dermatology. 227(3). 238–242. 10 indexed citations
9.
Chevalier, Nicolas, et al.. (2012). GPR30, the non classical membrane G protein related estrogen receptor (GPER), is overexpressed in human seminoma and promotes seminoma cell proliferation.. 15th International & 14th European Congress of Endocrinology. 29. 1 indexed citations
10.
Fachal, Laura, Antonio Gómez‐Caamaño, Paula Peleteiro, et al.. (2012). Association of a XRCC3 polymorphism and rectum mean dose with the risk of acute radio-induced gastrointestinal toxicity in prostate cancer patients. Radiotherapy and Oncology. 105(3). 321–328. 32 indexed citations
11.
Fachal, Laura, L. Rodríguez‐Pazos, Manuel Ginarte, et al.. (2012). Multiple Local and Recent Founder Effects of TGM1 in Spanish Families. PLoS ONE. 7(4). e33580–e33580. 10 indexed citations
12.
Vega, Ana, Celia Pérez‐Cerdá, Lourdes R. Desviat, et al.. (2009). Functional analysis of three splicing mutations identified in the PMM2 gene: Toward a new therapy for congenital disorder of glycosylation type Ia. Human Mutation. 30(5). 795–803. 44 indexed citations
13.
Castellvı́-Bel, Sergi, Ceres Fernández–Rozadilla, Francesc Balaguer, et al.. (2009). Molecular analysis of the APC and MUTYH genes in Galician and Catalonian FAP families: a different spectrum of mutations?. BMC Medical Genetics. 10(1). 57–57. 37 indexed citations
14.
Cerezo, María, Hans‐Jürgen Bandelt, Idoia Martín‐Guerrero, et al.. (2009). High Mitochondrial DNA Stability in B-Cell Chronic Lymphocytic Leukemia. PLoS ONE. 4(11). e7902–e7902. 19 indexed citations
15.
Ares, María Teresa Rodríguez, Ihab Abdulkader, Ana Blanco, et al.. (2007). Ligneous conjunctivitis: a clinicopathological, immunohistochemical, and genetic study including the treatment of two sisters with multiorgan involvement. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 451(4). 815–821. 19 indexed citations
16.
Graña, Begoña, Ana Vega, & Juan Cueva. (2005). Cáncer de mama y ovario hereditario:consejo genético, seguimiento y reducción del riesgo. Complutensian Scientific Journals (Complutense University of Madrid). 2(2). 229–242. 1 indexed citations
17.
Vega, Ana, Josema Torres, María Torres, et al.. (2003). A Novel Loss-of-Function Mutation (N48K) in the PTEN Gene in a Spanish Patient with Cowden Disease. Journal of Investigative Dermatology. 121(6). 1356–1359. 16 indexed citations
18.
Osório, Ana, Miguel de la Hoya, Raquel Rodríguez‐López, et al.. (2003). Over-representation of two specific haplotypes among chromosomes harbouring BRCA1 mutations. European Journal of Human Genetics. 11(6). 489–492. 15 indexed citations
19.
Ruíz-Ponte, Clara, Ana Vega, Ángel Carracedo, & Francisco Barros. (2001). Mutation analysis of the adenomatous polyposis coli (APC) gene in northwest Spanish patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer. Human Mutation. 18(4). 355–355. 24 indexed citations
20.
Vega, Ana, et al.. (1998). Minisatellite variant repeat (MVR) analysis of the HRAS1 minisatellite locus. Electrophoresis. 19(18). 3084–3089. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026